A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Anileridine
Gabexate
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Gabexate.
Anileridine
Monteplase
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Monteplase.
Anileridine
Nafamostat
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Nafamostat.
Anileridine
Darexaban
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Darexaban.
Anileridine
Letaxaban
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Letaxaban.
Anileridine
Antithrombin III human
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Antithrombin III human.
Anileridine
Protein C
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Protein C.
Anileridine
Antithrombin Alfa
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Antithrombin Alfa.
Anileridine
Zinc citrate
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Zinc citrate.
Anileridine
Desirudin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Desirudin.
Anileridine
Parnaparin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Parnaparin.
Anileridine
Bemiparin
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Bemiparin.
Anileridine
Dextran
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Dextran.
Anileridine
Sodium citrate
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Sodium citrate.
Anileridine
Potassium citrate
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Potassium citrate.
Anileridine
Edoxaban
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Edoxaban.
Anileridine
Vorapaxar
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Vorapaxar.
Anileridine
Ditazole
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Ditazole.
Anileridine
Ticagrelor
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Ticagrelor.
Anileridine
Triflusal
The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Triflusal.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3